Arduous investigation of the origin of Covid-19 in Wuhan | World

02/02/2021 Health, World



[ad_1]

On December 31, 2019, the Hoa Nam Seafood Market was closed overnight after being involved in 4 cases of “strange pneumonia”. By the end of January 2020, Wuhan had experienced 76 days of lockdown.

However, it is not until 31.1.2021 that the WHO research team reaches the Hoa Nam market, according to Reuters.

Suspected “escape” virus

On the last day of 2019, the WHO Country Office in China discovered the news of “viral pneumonia” on the website of the Vu Han City Health Committee and asked the local authorities to provide more information. On March 3, 2020, China began updating the WHO information on the outbreak of the “rare pneumonia” disease in Wuhan.
It took the Beijing authorities almost a week to inform the WHO that the “culprit” of the disease was a new strain of the Corona virus, which had never been discovered before. Three days later, the WHO announced that “preliminary investigations by China found no evidence of person-to-person transmission.”

The WHO launched an investigation into the origin of Covid-19 in Wuhan, “there is no guarantee that there will be an answer”
On January 23, 2020, Wuhan was officially blocked after the number of new infections skyrocketed, many people died, and some countries began to confirm the first cases. At the time, the western media reiterated, an American biosafety expert, Tim Trevan, warned in 2017 in the journal Nature about the risk of the virus spreading from the laboratory that opened the same year in Wuhan. It is the Wuhan National Biosafety Laboratory, located about 36 km from the outbreak of the Hunan Seafood Market. Another laboratory on site is the Wuhan Institute of Virology, also in the city.

All kinds of obstacles

On January 30, 2020, the WHO declared the new outbreak of the Corona virus that causes Wuhan pneumonia as “a global medical emergency”, but has made no recommendations on travel restrictions or trade restrictions with China.

At this point, the world is pressuring China to allow a delegation of WHO experts to come to Beijing to find out what is going on. However, it took almost two weeks for Beijing on September 9, 2020 to agree on the composition of the experts present in the delegation, according to Reuters. At first, the Hubei authorities refused to receive the delegation due to the critical period against Covid-19, but they eventually relented. However, this trip did not draw conclusions about the origin of the epidemic.

The EU drastically “won” the Covid-19 vaccine, which could block exports
In April 2020, then-US President Donald Trump announced that he would stop contributing funds to the WHO, accusing the organization of being biased towards China and failing to fulfill its responsibilities, and calling Covid-19 a ” virus. China “. On April 22, 2020, Australia requested an independent investigation to determine the origin of Covid-19. Almost a month later, Mike Pompeo, then secretary of state, accused China of refusing to give investigators access to suspicious facilities in Wuhan, such as the two labs mentioned above and the Flower Market.

It was not until August last year that a group of two WHO experts completed the investigation prior to the exit of the investigation of the origin of Covid-19. On December 18, 2020, the WHO announced that it would send the investigation team to Wuhan in January this year.

However, on June 6, WHO Director General Tedros Adhanom expressed disappointment that the organization’s experts had not yet received a visa to enter Beijing, prompting them to leave for China, but they had to to return. Almost a week later, Beijing confirmed that the WHO delegation would come to Wuhan. And it wasn’t until January 31 that the field investigation began.

Covid-19 Bulletin Feb 1: Hanoi became a new ‘hot spot’ and Bac Giang appeared to infect the community.

AstraZeneca increases vaccine supply to the EU

The pharmaceutical company AstraZeneca (UK) has pledged to increase the number of Covid-19 vaccines distributed to European Union (EU) countries by 30%. Last week, it announced that it could deliver only about a quarter of its committed doses to the EU in the first quarter of this year, due to some problems at a factory in Europe.

However, AFP quoted European Commission President Ursula von der Leyen on February 1 as saying that the company has just agreed to provide an additional 9 million doses and will begin distribution a week earlier than planned. A source said the first shipments will be delivered in the second week of February. Furthermore, according to Ms Von der Leyen, AstraZeneca will also increase vaccine production in Europe. The information was released after she argued with leaders of pharmaceutical companies that had signed contracts to supply the Covid-19 vaccine to the EU.

Khanh An




[ad_2]

Designed by Tricksfast Solutions
© Copyright 2024, All Rights Reserved